Treating Arterial Hypertension Through Stem Cell Therapy
Hypertension is a potentially devastating medical condition that increases blood pressure.  Known as a silent disease, hypertension generally doesn't involve symptoms that are easily recognized by most individuals until damage to blood vessels or cardiac health is realized.

In most cases, hypertension, also called arterial hypertension, is treated with a variety of drugs that may involve the use of diuretics, Beta blockers, ACE  inhibitors, and calcium channel blockers. However, research into stem cell therapies that may help reduce or reverse symptoms of hypertension are currently under study in a variety of stem cell research facilities around the globe.

Basically defined as elevated blood pressure, arterial hypertension places added strain on the heart muscle in providing adequate flow of oxygen rich blood to all the body's tissues and organs. In some cases, the transplantation of embryonic stem cells may help provide relief, reducing blood pressure and the need for hypertensive therapy treatments.

To date, embryonic stem cell treatments for hypertension have shown efficacy in reducing blood pressure, frequency of headaches, and a stabilization of blood pressure, leading to enhanced mental capacity and abilities, rejuvenation, and sexual performance and potency in men and women.

A variety of facilities throughout Europe, the Netherlands, and Ukraine have offered and performed treatments, clinical trials and studies regarding the efficacy of stem cell therapies to improve heart function. Studies performed in the Netherlands have shown that allogenic stem cell therapies improved function of the right ventricular portion of the heart as well as lung capacity in small animals with pulmonary hypertension.

Embryonic stem cells have the ability to differentiate, or become any type of cell in the human body, offering unique opportunities to replace damaged cells and tissues in the human body.  Replacing damaged cells with healthy cells is the foundation of stem cell transplantation and implantation therapies and treatment studies.

Researchers believe that some types of stem cells found in the body may contribute to the thickening of blood vessels, leading to various types of hypertension, including pulmonary hypertension. Other researchers believe that embryonic or other progenitor stem cells have the capability of repairing damaged blood vessels and tissues, restoring normal blood flow throughout the body and to the lungs.

Healthy stem cells are cultivated in a laboratory environment and then injected or transfused into a person suffering from arterial or pulmonary hypertension. While the technology is still very new, it is an area of intense and concentrated research in stem cell research facilities around the world.

According to the Pulmonary Hypertension Association, the use of stem cell therapies for PAH (pulmonary arterial hypertension), also known as primary pulmonary hypertension, has shown promising benefits. Clinical trials are under way in the United States and Canada, while stem cell therapies conducted around the globe have also shown promising results.